[1]杨天伦,综述.内皮损伤与阿司匹林内皮保护作用[J].心血管病学进展,2016,(2):164-167.[doi:10.16806/j.cnki.issn.1004-3934.2016.02.017]
　YANG Tianlun.Endothelial Injury and Protective Effect of Aspirin[J].Advances in Cardiovascular Diseases,2016,(2):164-167.[doi:10.16806/j.cnki.issn.1004-3934.2016.02.017]
点击复制

内皮损伤与阿司匹林内皮保护作用()
分享到：

《心血管病学进展》[ISSN:51-1187/R/CN:1004-3934]

卷:
期数:
2016年2期
页码:
164-167
栏目:
综述
出版日期:
2016-04-20

文章信息/Info

Title:
Endothelial Injury and Protective Effect of Aspirin
作者:
杨天伦; 综述
中南大学湘雅医院心内科,湖南 长沙 410008
Author(s):
YANG Tianlun
Department of Cardiology,Xiangya Hospital of Centre-south University, Changsha 410008, Hunan, China
关键词:
内皮损伤;  阿司匹林;  内皮保护
Keywords:
Endothelial injury;  Aspirin;  Endothelial protection
分类号:
R 973+2
DOI:
10.16806/j.cnki.issn.1004-3934.2016.02.017
文献标志码:
A
摘要:
血管内皮细胞除作为血液与间质组织间的屏障外,还可分泌多种活性物质,以保持血管舒张及收缩因子间的平衡,参与血小板功能调节和凝血因子的清除和纤维溶解过程,调节血管平滑肌生长; 调节炎症和免疫反应过程。一旦在某种或多种危险因素的作用下发生血管内皮损伤,引起内皮功能障碍,从而导致一系列的病理生理反应、血管重构和斑块形成,因此内皮损伤是动脉粥样硬化发生的始动因素和关键环节。对于动脉粥样硬化事件的预防,在内皮损伤发生之时即应启动,多项研究证实经典抗血小板药物阿司匹林具有显著的内皮保护作用,可显著修复改善内皮依赖性血管舒张功能。现对内皮损伤及阿司匹林的内皮保护作用进展做简要概述,从而强化临床医生对于内皮损伤的认识,在心血管疾病的发生发展过程中及早给予干预,最大程度地延缓疾病的进展。
Abstract:
Vascular endothelial cells, except as a barrier between the blood and interstitial tissue, can secrete a variety of bioactive substances to maintain the balance between vascular relaxation and contraction factors.As well as regulate platelet function, clearance and fibrinolysis of coagulation factor, which can also regulate vascular smooth muscle growth and inflammatory and immune responses.Once the vascular endothelial injury occurred causing endothelial dysfunction due to one or more risk factors, it will result in a series of pathological and physiological reactions, vascular remodeling and plaque formation, so endothelial injury is the initiating factor and key link of atherosclerosis.The prevention of an atherosclerosis event should be initiated at the time of the endothelial injury occurrence.A number of studies have confirmed that the classic antiplatelet drug aspirin possesses significant endothelial protection, which can significantly improve the endothelium dependent vascular relaxation function.In this article, we will offer a brief overview of endothelial injury and the protective effect of aspirin, thereby strengthening understanding of endothelial injury, providing intervention as soon as possible in the development of cardiovascular disease to delay the disease progression to the full extent.

参考文献/References:

[1] Ross R.Atherosclerosis—an inflammatory disease[J]. N Engl J Med,1999,340(2):115-126.
[2] Widmer RJ, Lerman A.Endothelial dysfunction and cardiovascular disease[J].Glob Cardiol Sci Pract,2014,2014(3):291-308.
[3] Celermajer DS, Sorensen KE, Bull C,et al. Endothelium-dependent dilation in the systemic arteries of asymptomatic subjects relates to coronary risk factors and their interaction[J]. J Am Coll Cardiol,1994,24(6):1468-1474.
[4] Peng H, Han SH, Liu HY,et al. Relationship of inflammation and endothelial dysfunction with risks to cardiovascular disease among people in Inner Mongolia of China[J]. Biomed Environ Sci, 2013,26(10):792-800.
[5] Szpak D, Grochowalski A, Chrzαszcz R,et al.Tobacco smoke exposure and endothelial dysfunction in patients with advanced coronary artery disease[J]. Pol Arch Med Wewn,2013,123(9):474-481.
[6] Zhu J, Wang X, Chen J,et al.Reduced number and activity of circulating endothelial progenitor cells from patients with hyperhomocysteinemia[J]. Arch Med Res,2006,37(4):484-489.
[7] Kurtogˇlu Gümü �瘙 塂 el H, Çatakogˇlu AB, Ylldlrlmtürk Ö,et al.Relationship between endothelial dysfunction and cardiovascular risk factors and the extent and severity of coronary artery disease[J]. Turk Kardiyol Dern Ars, 2014,42(5):435-443.
[8] Lind L, Berglund L, Larsson A,et al.Endothelial function in resistance and conduit arteries and 5-year risk of cardiovascular disease[J]. Circulation,2011,123(14):1545-1551.
[9] van Sloten TT, Henry RM, Dekker JM,et al.Endothelial dysfunction plays a key role in increasing cardiovascular risk in type 2 diabetes: the Hoorn study[J]. Hypertension,2014,64(6):1299-1305.
[10] Gupta AK, Ravussin E, Johannsen DL,et al.Endothelial Dysfunction: An Early Cardiovascular Risk Marker in Asymptomatic Obese Individuals with Prediabetes[J]. Br J Med Med Res,2012,2(3):413-423.
[11] 门剑龙,任静.vWF在评估血管内皮功能异常疾病中的研究进展[J].中华检验医学杂志, 2011,34(12):1165-1168.
[12] 谭元生,张稳. 原发性高血压病人血管性假血友病因子及超敏C反应蛋白的检测意义[J].中西医结合心脑血管病杂志,2007,5(9):810-811.
[13] 童海.高敏C反应蛋白与动脉粥样硬化[J].中国动脉硬化杂志,2010,18(9):746-750.
[14] 杨娉婷,袁洪,王雅琴,等.高血压前期体检人群血管内皮功能及其与脉搏波传导速度的关系[J].中国动脉硬化杂志,2014,22(5):472-476.
[15] 李贤.内皮细胞微粒的研究进展[J].国际检验医学杂志,2015,36(4):522-524.
[16] Teragawa H, Mitsuba N, Ishibashi K,et al.Positive influence of aspirin on coronary endothelial function:importance of the dose[J]. World J Cardiol,2013,5(11):426-433.
[17] Xie M, Shan Z, Zhang Y,et al. Aspirin for primary prevention of cardiovascular events: meta-analysis of randomized controlled trials and subgroup analysis by sex and diabetes status[J]. PLoS One,2014,9(10):e90286.
[18] Grosser N, Schröder H.Aspirin protects endothelial cells from oxidant damage via the nitric oxide-cGMP pathway[J]. Arterioscler Thromb Vasc Biol,2003,23(8):1345-1351.
[19] Chang PY, Chen YJ, Chang FH,et al. Aspirin protects human coronary artery endothelial cells against atherogenic electronegative LDL via an epigenetic mechanism: a novel cytoprotective role of aspirin in acute myocardial infarction[J]. Cardiovasc Res,2013,99(1):137-145.
[20] Ou HC, Lee WJ, Wu CM,et al. Aspirin prevents resistin-induced endothelial dysfunction by modulating AMPK, ROS, and Akt/eNOS signaling[J]. J Vasc Surg,2012,55(4):1104-1115.
[21] Chen B, Zhao J, Zhang S,et al. Aspirin inhibits the production of reactive oxygen species by downregulating Nox4 and inducible nitric oxide synthase in human endothelial cells exposed to oxidized low-density lipoprotein[J]. J Cardiovasc Pharmacol,2012,59(5):405-412.
[22] Silverman MG, Blaha MJ, Budoff MJ,et al.Potential implications of coronary artery calcium testing for guiding aspirin use among asymptomatic individuals with diabetes[J]. Diabetes Care,2012,35(3):624-626.

相似文献/References:

[1]杜旭江 吕依晨 王少兰 王海芳 韩曼.孕烷X受体在心血管疾病中的作用机制及中药调控研究进展[J].心血管病学进展,2022,(6):547.[doi:10.16806/j.cnki.issn.1004-3934.2022.06.017]
　DU Xujiang,LV Yichen,WANG Shaolan,et al.Pregnane X Receptor in Cardiovascular Disease and Intervention Mechanism of Traditional Chinese Medicine[J].Advances in Cardiovascular Diseases,2022,(2):547.[doi:10.16806/j.cnki.issn.1004-3934.2022.06.017]
[2]朱栋 何翔 李国平.基于Virchow三要素浅谈环境污染与肺栓塞疾病[J].心血管病学进展,2022,(11):984.[doi:10.16806/j.cnki.issn.1004-3934.2022.11.005]
　ZHU Dong,HE Xiang,LI Guoping.Discussing Environmental Pollution and Pulmonary Embolic Disease Based on?irchows Triad[J].Advances in Cardiovascular Diseases,2022,(2):984.[doi:10.16806/j.cnki.issn.1004-3934.2022.11.005]

备注/Memo

备注/Memo:
作者简介:杨天伦(1957—),教授,博士,博士生导师,主要从事高血压病防治、冠心病介入治疗、心力衰竭治疗、心血管危重症病抢救及心理治疗研究。Email:tianluny@163.com
更新日期/Last Update: 2016-03-25